(1)
Pharmacotherapeutic Follow-up in Patients With Type 1 Diabetes in Context of Judicialization: Possibility Optimize Costs. Braz. J. Pharm. Sci. 2023, 59, e23264. https://doi.org/10.1590/s2175-97902023e23264.